Chamber and committees

The cervical screening programme routinely invites anyone with a cervix who is between the ages of 25 and 64 for a test every 5 years. This is in line with the recommendation given by the UK National Screening Committee (UK NSC), to change the primary screening test from cytology (looking at cervical cells through a microscope to find those which could develop into cancer) to testing for high-risk human papillomavirus (HPV). The new test is more effective at identifying those at risk of developing cervical cancer, meaning those who don’t have HPV will be invited for a cervical screening test every five years instead of every three. The Scottish Government, along with the rest of the UK, is advised on all aspects of cervical screening including the move to HPV testing by the UK NSC.

Further information on the UK NSC’s recommendation can found on the following website: https://view-health-screening-recommendations.service.gov.uk/cervical-cancer/.

The Scottish Government is clear that we wish to maintain and advance the high standards Scotland has enjoyed as part of the EU. Ministers have no current plans to use the discretionary powers to align with the European Union legislation provided through the UK Withdrawal from the EU (Continuity) (Scotland) Act 2021 in the area of nature restoration legislation.

Ministers will set out a statement of policy on the factors to be taken into account when considering whether to use the discretionary power within the UK Withdrawal from the EU (Continuity) (Scotland) Act 2021 in the coming months .

The Scottish Government does not hold information on the newborn hearing test and newborn infant physical examination. These would need to be requested from health boards directly.

The following table shows the number of babies screened using the bloodspot test in the newborn screening programme between January 2019 and July 2021.

It is important to note that the data provided below is management information and has not been subject to the necessary quality checks carried out for an official publication.

As part of the NHS Scotland response to coronavirus (COVID-19), an Innovation Workstream has been created to manage the evaluation of antibody and swab (PCR) tests. This workstream is led by NHS NSS and clinical scientists from NHS Health Boards, and is designed to take advantage of rapid innovations within testing, while at the same time avoiding duplication of effort between Health Boards.

As part of this workstream, antibody tests being used within Scotland are validated by NHS Scotland. The evaluation reports for the antibody assays which have currently been validated and are in use are publicly available, and can be found on NHS Scotland’s Health Innovation Assessment Portal . These evaluation reports show the high sensitivity and specificity of antibody tests approved for use within Scotland.

Scotland is also part of the UK National Testing Programme, participating in UK-wide antibody studies such as the Post Positive PCR Antibody Testing Initiative, where antibody tests have been validated by the UK Government. These validation reports are publicly available, and can be found on the UK Government website .

Yes.

We are still in the early stages of development in relation to the Carbon Neutral Islands project, and are engaging relevant stakeholders to ensure that the voices of islanders are fully heard. It is therefore too soon to determine how much funding will be needed.

A public consultation on the draft Framework for Chronic Pain Service Delivery is expected to begin this Autumn. We are grateful for the input provided to date by people with lived experience, clinical, third-sector and other stakeholders in helping us to shape this draft and welcome further feedback as part of the public consultation in order to help us improve services and support for people with chronic pain in Scotland.

By developing Carbon Neutral Islands that attract jobs and investment, the project aims to retain and bring more people to Scottish islands. It will be informed by the development of the Islands Bond policy and align with Strategic Objective One of the National Islands Plan which states that we will address population decline and ensure a healthy, balanced population profile.

In May 2021, we allocated £16.4 million to support NHS Boards to implement the National Child and Adolescent Mental Health Services (CAMHS) Service Specification. In addition, on 14 September, we announced £10.83 million funding to further support the implementation. Through this funding, NHS Boards have started to recruit additional staff to implement the Specification and to build professional capacity to support children and young people with neurodevelopmental support needs.

The Scottish Government is not responsible for the recruitment of NHS staff. It is NHS Boards’ responsibility to recruit workforce. The Scottish Government has provided guidance to NHS Boards, through the National CAMHS Service and Neurodevelopmental Specifications, on the appropriate roles and professionals expected to be employed within Boards.